Alchemab Therapeutics
ID: 7684264Alchemab Therapeutics is a developer of natural protective antibodies founded in 2019 by Uri Laserson, Jane Osbourn and Rachael Bashford Rogers.
2
Funding Rounds
$114.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja** Os***** |
|
- | |
| Ra***** Ba****** Ro**** |
|
- | |
| Ur* La****** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Alchemab Therapeutics has raised a total of $114.4m in funding over 2 rounds.
Key Insights:
- Alchemab Therapeutics Series A Round, September 2025: $32m
- Alchemab Therapeutics Series A round, April 2021: $82.4m
Industries
Alchemab Therapeutics is active in the following industries: